Drugmakers’ hopes for gene therapy rise despite tiny sales in Europe – eNCA
eNCA |
Drugmakers’ hopes for gene therapy rise despite tiny sales in Europe
eNCA After decades of frustrations, firms believe there are now major opportunities for gene therapy in treating inherited conditions such as haemophilia. They argue that therapies offering one-off cures for intractable diseases will save health providers … |
pharmaphorum |
Kite begins EU trial of CAR–T therapy
pharmaphorum Axicabtagene ciloleucel is an investigational therapy in which a patient’s T cells are engineered to express a chimeric antigen receptor (CAR) to target the antigen CD19 – a protein expressed on the cell surface of B-cell lymphomas and leukaemias – and … Kite Submits Investigational New Drug (IND) Application for KITE-585, Anti-BCMA CAR–T Therapy Candidate for …Business Wire (press release) Prepping for a rapid-fire launch, Kite Pharma gets a pass from FDA on axi-cel panel reviewEndpoints News Kite Pharma (KITE) Q2 Loss Narrower than Expected, Sales BeatNasdaq Modern Readers –Zacks Investment Research all 52 news articles » |
Reuters |
Drugmakers’ hopes for gene therapy rise despite tiny sales in Europe
Reuters LONDON (Reuters) – The science of gene therapy is finally delivering on its potential, and drugmakers are now hoping to produce commercially viable medicines after tiny sales for the first two such treatments in Europe. Thanks to advances in delivering … |
Reuters |
Drugmakers’ hopes for gene therapy rise despite tiny sales in Europe
Reuters LONDON (Reuters) – The science of gene therapy is finally delivering on its potential, and drugmakers are now hoping to produce commercially viable medicines after tiny sales for the first two such treatments in Europe. Thanks to advances in delivering … |
WHTC |
Drugmakers’ hopes for gene therapy rise despite tiny sales in Europe
WHTC LONDON (Reuters) – The science of gene therapy is finally delivering on its potential, and drugmakers are now hoping to produce commercially viable medicines after tiny sales for the first two such treatments in Europe. Thanks to advances in delivering … |
ISRAEL21c |
Stem–cell treatment may harm heart disease patients
ISRAEL21c “We found that, contrary to popular belief, tissue stem cells derived from sick hearts do not contribute to heart healing after injury,” said Leor. “Furthermore, we found that these cells are affected by the inflammatory environment and develop … Is stem cell injection the cure-all miracle?Health24 Global Stem Cell Banking Market analysis studied in new research Forecast to 2021Medgadget (blog) Global Pipeline Drugs for Hematopoietic Stem Cell Transplantation Market 2017 – Actimab-B, Balixafortide, BL-8040 …Digital Journal satPRnews (press release) all 13 news articles » |